Back to search

University of Alabama Birmingham

Voltage-Gated Sodium Channel Nav1.7 Subtype: A Promising Therapeutic Target For Metastatic Medullary Thyroid Cancer

Abstract

dc:description.abstract

Medullary thyroid carcinoma (MTC), a rare neuroendocrine tumor, presents considerable clinical challenges due to its tendency to metastasize to organs such as the liver, bones, and brain, resulting in poor patient outcomes. Voltage-gated sodium channels (VGSCs) have emerged as potential therapeutic targets in various malignancies due to their crucial role in promoting cancer cell progression, migration, invasion, and metastasis. This dissertation investigates the specific contributions of the VGSC NaV1.7 subtype in MTC, evaluating its potential as a therapeutic target and elucidating its mechanistic involvement in MTC. Initially, we assessed VGSC subtypes expression in MTC cells. The screening revealed an overexpression of NaV1.7 in metastatic MTC cell line, MZ-CRC-1 relative to primary MTC cell line, TT and normal thyroid cell lines. Immunohistochemical analysis of MTC patient tissues compared to normal thyroid tissues further supported these findings, identifying NaV1.7 as a promising biomarker for MTC progression and a potential therapeutic target. Subsequently, a small-molecule NaV1.7 inhibitor, SV188, was identified and characterized. SV188 exhibited potent inhibition of sodium currents and significantly reduced migration, and invasion of MTC cells in vitro. Moreover, SV188 prevented liver metastasis in a metastatic MTC mouse model, underscoring its potential as a novel anti-metastatic therapeutic agent for MTC. We extended this investigation by designing, synthesizing, and evaluating 17 analogs of SV188 through ligand-based and structure-activity relationship (SAR) studies. The structure modifications at the phenyl rings and head group enhanced sodium current blockade while reducing toxicity. Notably, one analog, IIB7, which is less toxic toward MZ-CRC-1 (CC50 > 100 μM) achieved a 71% reduction in MTC cell invasion, marking an improvement in the reduction of MTC metastasis. Finally, the mechanistic role of NaV1.7 in MTC metastasis was investigated. Knockdown of NaV1.7 in MZ-CRC-1 cells using RNA interference (RNAi) led to significant reductions in cell migration, invasion, and the mRNA expression of 15 genes associated with metastasis. These findings suggest that NaV1.7 is a critical regulator of metastasis-related pathways in MZ-CRC-1 cells. In summary, this dissertation elucidates the critical involvement of NaV1.7 in MTC metastasis and presents innovative NaV1.7 inhibitors as potential therapeutic strategies to attenuate metastatic progression of MTC.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pukkanasut, Piyasuda
Contributors dc:contributor
  • <p>Sadanandan Velu</p>
  • <p>Anna Sorace<br>Hui-Ting Lee<br>Pengfei Wang<br>Renata Jaskula-Sztul</p>

Subjects

dc:subject × 3

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Pukkanasut, Piyasuda. Voltage-Gated Sodium Channel Nav1.7 Subtype: A Promising Therapeutic Target For Metastatic Medullary Thyroid Cancer. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-collection/7304